Correlation Between Novozymes A/S and Halma Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novozymes A/S and Halma Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novozymes A/S and Halma Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novozymes AS B and Halma plc, you can compare the effects of market volatilities on Novozymes A/S and Halma Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novozymes A/S with a short position of Halma Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novozymes A/S and Halma Plc.

Diversification Opportunities for Novozymes A/S and Halma Plc

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novozymes and Halma is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Novozymes AS B and Halma plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halma plc and Novozymes A/S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novozymes AS B are associated (or correlated) with Halma Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halma plc has no effect on the direction of Novozymes A/S i.e., Novozymes A/S and Halma Plc go up and down completely randomly.

Pair Corralation between Novozymes A/S and Halma Plc

Assuming the 90 days horizon Novozymes AS B is expected to under-perform the Halma Plc. In addition to that, Novozymes A/S is 1.25 times more volatile than Halma plc. It trades about -0.18 of its total potential returns per unit of risk. Halma plc is currently generating about 0.13 per unit of volatility. If you would invest  3,156  in Halma plc on August 25, 2024 and sell it today you would earn a total of  161.00  from holding Halma plc or generate 5.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Novozymes AS B  vs.  Halma plc

 Performance 
       Timeline  
Novozymes AS B 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS B has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Halma plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Halma plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Halma Plc is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Novozymes A/S and Halma Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novozymes A/S and Halma Plc

The main advantage of trading using opposite Novozymes A/S and Halma Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novozymes A/S position performs unexpectedly, Halma Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halma Plc will offset losses from the drop in Halma Plc's long position.
The idea behind Novozymes AS B and Halma plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios